Calcium and vitamin D supplementation with 3-year denosumab treatment is beneficial to enhance bone mineral density in postmenopausal patients with osteoporosis and rheumatoid arthritis
2018 ◽
Vol Volume 15
◽
pp. 15-22
◽
Keyword(s):
Keyword(s):
2021 ◽
Vol Publish Ahead of Print
◽
Keyword(s):
2017 ◽
Vol 78
(1)
◽
pp. 11-19
Keyword(s):
Keyword(s):
2020 ◽
Vol 101
(11)
◽
pp. e51-e52
Keyword(s):